The scale of capital flowing into artificial intelligence was starkly illustrated this week, led by a projection that hyperscalers will invest a cumulative $3 trillion in AI infrastructure over the next three years. According to an executive from Everpure, this spending by giants like Amazon, Microsoft, Alphabet, and Meta Platforms dwarfs many national budgets. At the venture level, Indian startup Sarvam AI secured $234 million in a significant funding round backed by investors including HCLTech, Bessemer Venture Partners, Khosla Ventures, and Peak XV Partners, reinforcing strong investor appetite for foundational AI development.
This massive infrastructure spending is intensifying the focus on the semiconductor supply chain. In the United States, major technology firms including Apple, Microsoft, Google, and Intel have formed the U.S. Semiconductor Alliance, a new coalition advocating for $50 billion in government subsidies to bolster domestic chip manufacturing. The move comes as Intel entered risk production for its 18A-P process node and announced a manufacturing collaboration with Apple. The strategic importance of silicon was further highlighted by reports that SpaceX has secured 20% of NVIDIA’s next-generation chip allocation, signaling fierce competition for advanced computing resources.
Amid the hardware buildout, the pace of model innovation continued unabated. Google announced a significant update to its Gemini 2.5 Pro, enhancing its reasoning and coding capabilities for subscribers and API users. The company also rolled out Gemini 3.5 Live Translate, offering real-time speech-to-speech translation in over 70 languages. Meanwhile, Chinese firm Zhipu AI released GLM-5.2, a powerful 744-billion-parameter Mixture-of-Experts model specialized for coding, featuring a 1-million-token context window and an open-weight release for broader developer access.
However, the rapid advancement of AI capabilities is attracting increased government scrutiny. In a significant development, Anthropic was forced to suspend global access to its newly launched Fable 5 and Mythos 5 models following a directive from the U.S. Department of Commerce. The move, framed as an export control measure, has sparked debate, with cybersecurity experts arguing that it removes critical defensive AI tools from the market. The suspension underscores the growing geopolitical and national security dimensions of cutting-edge AI, creating uncertainty for developers and users reliant on these advanced systems.
Beyond the core technology sector, AI's commercial impact is expanding into highly specialized industries like pharmaceuticals. This week, South Korean chemical company LG Chem announced a partnership with UK-based LabGenius Therapeutics to accelerate cancer drug discovery. The collaboration will leverage LabGenius's AI-powered platform to develop next-generation antibody therapies, with the goal of halving the typical discovery timeline and bringing new treatments to market more quickly.